Vanguard Global Advisers
BLFS icon

Vanguard Global Advisers’s BioLife Solutions BLFS Stock Holding History

Vanguard Global Advisers’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Hold
15,264
– – ﹤0.01% 2170
2026
Q1 		$291K Buy
+15,264
New +$337K ﹤0.01% 2260

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Global Advisers's BLFS Position: Q2 2026 in Review

Vanguard Global Advisers held its BioLife Solutions (BLFS) position steady in Q2 2026 at 15,264 shares worth $431K. The position accounts for ﹤0.01% of the portfolio, ranked #2170.

Vanguard Global Advisers first reported a position in BLFS in Q1 2026 and has held it in 2 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Vanguard Global Advisers held 15,264 shares of BioLife Solutions worth $431K as of Q2 2026.
  • Vanguard Global Advisers left its BioLife Solutions share count unchanged in Q2 2026.
  • BioLife Solutions made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2170 holding.
  • Vanguard Global Advisers first reported a position in BioLife Solutions in Q1 2026 and has held it in 2 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.